How is the Dyne Therapeutics Inc today?

The Dyne Therapeutics Inc today is trading in the down by -2.29% at 11.96.

How has Dyne Therapeutics Inc performed historically?

The Dyne Therapeutics Inc is currently trading down -2.29% on an intraday basis in the past week the index rose 2.31%. The index has been down -9.19% in the past quarter and fell -61.67% in the past year. You can view this in the overview section.

What is Dyne Therapeutics Inc Annual Net Profit?

Dyne Therapeutics Inc Annual Net Profit fell 34.54% in the last year to $317.42 M. Its sector's average net profit growth for the last fiscal year was -11.09%.

What is Dyne Therapeutics Inc Price to Earning Ratio?

Dyne Therapeutics Inc Price to Earning Ratio is -3.7, which is negative.

What is Dyne Therapeutics Inc Stock Price?

Dyne Therapeutics Inc Stock Price fell 61.67% and underperformed its sector by 117.14% in the past year.

What is Dyne Therapeutics Inc Quarterly Net profit?

Dyne Therapeutics Inc Quarterly Net profit fell 75.72% YoY to $115.36 M. Its sector's average net profit growth YoY for the quarter was -212.88%.

What is Dyne Therapeutics Inc Debt to Equity Ratio?

Dyne Therapeutics Inc Debt to Equity Ratio of 0.04 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Dyne Therapeutics Inc Return on Equity(ROE)?

Dyne Therapeutics Inc Return on Equity(ROE) for the last financial year was -88.03%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Dyne Therapeutics Inc Mutual Fund Holding?

Dyne Therapeutics Inc Mutual Fund Holding decreased by 1.64% in the last quarter to 45.71.

What is Dyne Therapeutics Inc Institutional Holding?

Dyne Therapeutics Inc Institutional Holding increased by 7.31% in the last quarter to 98.87.

Dyne Therapeutics Inc XNAS: DYN

Dyne Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Dyne Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Dyne Therapeutics Inc
Rating: 0.96433325
Author: Trendlyne DVM scores

about

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therape...

11.96 -0.28 (-2.29%)

74.79% Fall from 52W High

1.1M XNAS Volume

XNAS 30 May, 2025 5:30 PM (EDT)

Board Meeting

The latest board meeting for Dyne Therapeutics Inc took place on 30 May 2025, for the purpose of Dyne Therapeutics Inc Annual General Meeting for 2025 See details

Not Eligible

Expensive Valuation

7.3 / 100

Technically Bearish

31.2 / 100

No estimates available

Dyne Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Dyne Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therape...

74.79% Fall from 52W High

SWOT Analysis

Dyne Therapeutics Inc Live Price Chart

Dyne Therapeutics Inc FAQ

How is Dyne Therapeutics Inc today?

Dyne Therapeutics Inc today is trading in the red, and is down by -2.29% at 11.96.

How has Dyne Therapeutics Inc performed historically?

Dyne Therapeutics Inc is currently trading down -2.29% on an intraday basis. In the past week the stock rose 2.31%. stock has been down -9.19% in the past quarter and fell -61.67% in the past year. You can view this in the overview section.